Author
Eliezer M. Van Allen
Recent research
- BiologyOpen access
PURPOSE: BRAF-targeted therapy (BRAFi/MEKi) and immune checkpoint blockade (anti-PD-1/anti-CTLA-4) have transformed the treatment of BRAF-mutant metastatic melanoma. While most patients who respond to targeted therapy eventually progress, a subset derives durable benefit, and bio...
- BiologyOpen access
Single-cell perturbation prediction near experimental reproducibility with GENESIS
Single-cell perturbation atlases now measure cellular responses across millions of cells, but the number of possible combinations of biological contexts, perturbations, doses and other experimental variables make exhaustive measurements infeasible. Here, we present GENESIS (Gener...
- Health & MedicineOpen access
Fusion-driven oncogenic programs shape the immune landscape in translocation renal cell carcinoma
Renal cell carcinomas comprise multiple molecularly distinct cancers but most are treated empirically with therapies designed for clear cell RCC (ccRCC), the most common subtype, due to incomplete understanding of subtype-specific biology. We analyzed single-cell transcriptomes a...